[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"National Institute of Hygiene and Epidemiology, Vietnam\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":55},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":32,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":54},"100568469",false,"NCT06681636","Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure","A Non-inferiority Study Comparing the Immunogenicity of a Standard or an Extended Three-dose Nonavalent Human Papillomavirus Vaccine Schedule Between High-risk Women Aged 18-26 Years and Age-matched Women in the General Population","HPV9vxFSW","Inclusion Criteria:\n\n* Is between the reporting ages of 18-26 years at the time of recruitment.\n* Engage in commercial sex in the last 6m (for FSW group) or have engaged in sexual activity (non-FSWs)\n* Willing and able to give written informed consent.\n* Willing to complete the follow-up requirements of the study.\n\nExclusion criteria\n\nParticipants meeting any of the following criteria will be excluded from the trial:\n\n* Pregnant or possibly pregnant\n* Has received any HPV vaccine previously\n* Has an axillary temperate greater than 38°C\n* Known allergies to any vaccine component\n* incapacity to provide consent\n* Currently receiving immunosuppressive medication or anti-cancer chemotherapy.\n* Known HIV infection.\n* Known Congenital immune deficiency syndrome.",true,"FEMALE","18 Years","26 Years",{"count":21,"type":22},300,"ESTIMATED","INTERVENTIONAL",[25],"PHASE2","A Study to evaluate if the 3 dose extended schedule (0-6-18 months) for the HPV vaccine Gardasil-9 provide similar immune responses and short term protection against HPV infection compared to the regular 3 dose schedule (0-2-6 months) in high risk women in Vietnam",[28,29,30,31],"HPV Infection","Cervical Cancer","Anogenital Cancer","Anogenital Warts",[33,34,35,36,37,38,39,40,41],"human papillomavirus","HPV vaccine","Vietnam","Female sex workers","immunogenicity","protection","extended schedule","HPV infection","cervical cancer","NOT_YET_RECRUITING","2024-11-07",{"date":45,"type":46},"2024-11-08","ACTUAL",{"date":48,"type":22},"2024-12-14",{"date":50,"type":22},"2027-12-31",{"name":52,"class":53},"National Institute of Hygiene and Epidemiology, Vietnam","OTHER",3,""]